Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Imai

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Chest|June 8, 2025
Anti-Ro52 Seropositive Interstitial Lung Disease Is Associated With a Higher Risk of Disease Progression and MortalityRyosuke Imai, Rene S Bermea, Sophia H Zhao, et al.
Scientific Reports|April 21, 2016
Chromatin folding and DNA replication inhibition mediated by a highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complexRyosuke Imai, Seiji Komeda, Mari Shimura, et al.
ACS Nano|October 10, 2023
An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell ResponsesRyotaro Oyama, Harumichi Ishigame, Hiroki Tanaka, et al.
JTO Clinical and Research Reports|August 9, 2022
The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLCHiroaki Kanemura, Hidetoshi Hayashi, Shuta Tomida, et al.
Infectious Diseases and Therapy|August 9, 2021
Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory FailureYuichiro Shindo, Yasuhiro Kondoh, Akiko Kada, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2024
Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047)Tetsuhiko Asao, Takehito Shukuya, Kohei Uemura, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Chest|June 8, 2025
Anti-Ro52 Seropositive Interstitial Lung Disease Is Associated With a Higher Risk of Disease Progression and MortalityRyosuke Imai, Rene S Bermea, Sophia H Zhao, et al.
Scientific Reports|April 21, 2016
Chromatin folding and DNA replication inhibition mediated by a highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complexRyosuke Imai, Seiji Komeda, Mari Shimura, et al.
ACS Nano|October 10, 2023
An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell ResponsesRyotaro Oyama, Harumichi Ishigame, Hiroki Tanaka, et al.
JTO Clinical and Research Reports|August 9, 2022
The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLCHiroaki Kanemura, Hidetoshi Hayashi, Shuta Tomida, et al.
Infectious Diseases and Therapy|August 9, 2021
Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory FailureYuichiro Shindo, Yasuhiro Kondoh, Akiko Kada, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2024
Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047)Tetsuhiko Asao, Takehito Shukuya, Kohei Uemura, et al.
Pageof 8